Ho Lun Wong

4.4k total citations
40 papers, 3.5k citations indexed

About

Ho Lun Wong is a scholar working on Molecular Biology, Biomaterials and Pharmaceutical Science. According to data from OpenAlex, Ho Lun Wong has authored 40 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 19 papers in Biomaterials and 11 papers in Pharmaceutical Science. Recurrent topics in Ho Lun Wong's work include Nanoparticle-Based Drug Delivery (14 papers), RNA Interference and Gene Delivery (13 papers) and Advanced Drug Delivery Systems (9 papers). Ho Lun Wong is often cited by papers focused on Nanoparticle-Based Drug Delivery (14 papers), RNA Interference and Gene Delivery (13 papers) and Advanced Drug Delivery Systems (9 papers). Ho Lun Wong collaborates with scholars based in United States, Canada and China. Ho Lun Wong's co-authors include Xiao Yu Wu, Reina Bendayan, Hui Xue, Andrew M. Rauth, Ying‐Zheng Zhao, Cui‐Tao Lu, Shimeng Liu, Ruixue Zhang, Xinqiao Tian and Niladri Chattopadhyay and has published in prestigious journals such as PLoS ONE, Biomaterials and Advanced Drug Delivery Reviews.

In The Last Decade

Ho Lun Wong

38 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ho Lun Wong United States 27 1.7k 1.6k 959 809 380 40 3.5k
Kaoxiang Sun China 34 1.2k 0.7× 1.4k 0.9× 889 0.9× 986 1.2× 397 1.0× 107 3.7k
Eduardo Ansorena Spain 17 1.4k 0.9× 1.1k 0.7× 987 1.0× 854 1.1× 193 0.5× 30 3.7k
Yuanying Pei China 27 1.5k 0.9× 1.5k 1.0× 757 0.8× 714 0.9× 206 0.5× 41 3.2k
Hayat Önyüksel United States 29 1.2k 0.7× 1.3k 0.9× 576 0.6× 584 0.7× 294 0.8× 81 3.1k
Lisa M. Kaminskas Australia 38 926 0.6× 1.6k 1.1× 668 0.7× 737 0.9× 534 1.4× 91 4.3k
Florence Delié Switzerland 29 1.3k 0.8× 1.2k 0.8× 893 0.9× 1.0k 1.3× 292 0.8× 72 3.9k
Svetlana Gelperina Russia 31 2.9k 1.8× 1.6k 1.0× 1.5k 1.5× 1.4k 1.8× 428 1.1× 85 5.0k
João Nuno Moreira Portugal 34 974 0.6× 2.1k 1.3× 664 0.7× 518 0.6× 410 1.1× 104 3.5k
Sherry Y. Wu United States 29 1.1k 0.7× 2.6k 1.7× 829 0.9× 397 0.5× 464 1.2× 66 4.4k
Etgar Levy‐Nissenbaum Israel 18 1.4k 0.9× 2.3k 1.5× 1.2k 1.2× 581 0.7× 159 0.4× 27 4.3k

Countries citing papers authored by Ho Lun Wong

Since Specialization
Citations

This map shows the geographic impact of Ho Lun Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ho Lun Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ho Lun Wong more than expected).

Fields of papers citing papers by Ho Lun Wong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ho Lun Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ho Lun Wong. The network helps show where Ho Lun Wong may publish in the future.

Co-authorship network of co-authors of Ho Lun Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Ho Lun Wong. A scholar is included among the top collaborators of Ho Lun Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ho Lun Wong. Ho Lun Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wong, Ho Lun, et al.. (2023). Polypharmacy and cumulative anticholinergic burden in older adults hospitalized with fall. Aging Medicine. 6(2). 116–123. 14 indexed citations
3.
Guo, Pengbo, et al.. (2022). Development of local injectable, bone-targeting nanocarriers of triptolide for treatment of bone-only metastasis. International Journal of Pharmaceutics. 625. 122092–122092. 6 indexed citations
4.
Wu, Di, et al.. (2017). Nanomedicine applications in the treatment of breast cancer: current state of the art. International Journal of Nanomedicine. Volume 12. 5879–5892. 153 indexed citations
5.
Zhao, Ying‐Zheng, Min Lin, Qian Lin, et al.. (2016). Intranasal delivery of bFGF with nanoliposomes enhances in vivo neuroprotection and neural injury recovery in a rodent stroke model. Journal of Controlled Release. 224. 165–175. 85 indexed citations
6.
Fetih, Gihan, et al.. (2016). Methocel-Lipid Hybrid Nanocarrier for Efficient Oral Insulin Delivery. Journal of Pharmaceutical Sciences. 105(5). 1733–1740. 28 indexed citations
7.
Fetih, Gihan, et al.. (2016). Development and evaluation of viscosity-enhanced nanocarrier (VEN) for oral insulin delivery. International Journal of Pharmaceutics. 511(1). 462–472. 29 indexed citations
8.
Lin, Qian, Ho Lun Wong, Furong Tian, et al.. (2016). Enhanced neuroprotection with decellularized brain extracellular matrix containing bFGF after intracerebral transplantation in Parkinson’s disease rat model. International Journal of Pharmaceutics. 517(1-2). 383–394. 29 indexed citations
9.
Zhang, Ruixue, et al.. (2016). Nanomedicine of synergistic drug combinations for cancer therapy – Strategies and perspectives. Journal of Controlled Release. 240. 489–503. 303 indexed citations
10.
Zhao, Ying‐Zheng, Xi Jiang, Jian Xiao, et al.. (2015). Using NGF heparin-poloxamer thermosensitive hydrogels to enhance the nerve regeneration for spinal cord injury. Acta Biomaterialia. 29. 71–80. 105 indexed citations
11.
Xue, Hui, et al.. (2014). Nanocarrier for Poorly Water-Soluble Anticancer Drugs—Barriers of Translation and Solutions. AAPS PharmSciTech. 15(4). 822–833. 198 indexed citations
12.
Lu, Cui‐Tao, Ying‐Zheng Zhao, Ho Lun Wong, et al.. (2014). Current approaches to enhance CNS delivery of drugs across the brain barriers. International Journal of Nanomedicine. 9. 2241–2241. 243 indexed citations
13.
Zhao, Ying‐Zheng, Haifeng Lv, Cui‐Tao Lu, et al.. (2013). Evaluation of a Novel Thermosensitive Heparin-Poloxamer Hydrogel for Improving Vascular Anastomosis Quality and Safety in a Rabbit Model. PLoS ONE. 8(8). e73178–e73178. 34 indexed citations
14.
Zhao, Ying‐Zheng, Haifeng Lv, Cui‐Tao Lu, et al.. (2013). Correction: Evaluation of a Novel Thermosensitive Heparin-Poloxamer Hydrogel for Improving Vascular Anastomosis Quality and Safety in a Rabbit Model. PLoS ONE. 8(9). 2 indexed citations
15.
Wong, Ho Lun, Zancong Shen, Ze Lu, M. Guillaume Wientjes, & Jessie L.‐S. Au. (2011). Paclitaxel Tumor-Priming Enhances siRNA Delivery and Transfection in 3-Dimensional Tumor Cultures. Molecular Pharmaceutics. 8(3). 833–840. 40 indexed citations
16.
Wong, Ho Lun, Niladri Chattopadhyay, Xiao Yu Wu, & Reina Bendayan. (2009). Nanotechnology applications for improved delivery of antiretroviral drugs to the brain. Advanced Drug Delivery Reviews. 62(4-5). 503–517. 174 indexed citations
17.
Li, Yongqiang, Ho Lun Wong, Adam J. Shuhendler, Andrew M. Rauth, & Xiao Yu Wu. (2008). Molecular interactions, internal structure and drug release kinetics of rationally developed polymer–lipid hybrid nanoparticles. Journal of Controlled Release. 128(1). 60–70. 86 indexed citations
18.
19.
Wong, Ho Lun, et al.. (2006). In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model. European Journal of Pharmaceutics and Biopharmaceutics. 65(3). 300–308. 87 indexed citations
20.
Wong, Ho Lun, et al.. (2004). Development of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizers. Journal of Pharmaceutical Sciences. 93(8). 1993–2008. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kaoxiang Sun Breakdown of academic impact, for papers by Eduardo Ansorena Breakdown of academic impact, for papers by Yuanying Pei Breakdown of academic impact, for papers by Hayat Önyüksel Breakdown of academic impact, for papers by Lisa M. Kaminskas Breakdown of academic impact, for papers by Florence Delié Breakdown of academic impact, for papers by Svetlana Gelperina Breakdown of academic impact, for papers by João Nuno Moreira Breakdown of academic impact, for papers by Sherry Y. Wu Breakdown of academic impact, for papers by Etgar Levy‐Nissenbaum
Rankless by CCL
2026